A Randomized Clinical Trial to Study the Effects of Infliximab on Clinical Efficacy and Hand and Wrist Magnetic Resonance Imaging (MRI) in Patients With Active Rheumatoid Arthritis (RA)(Protocol No. P08136)
Phase of Trial: Phase II
Latest Information Update: 16 May 2017
At a glance
- Drugs Infliximab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Schering-Plough
- 10 Jun 2017 Biomarkers information updated
- 11 Apr 2012 Actual patient number 61 added as reported by ClinicalTrials.gov.
- 11 Apr 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.